BIT's 16th Annual Congress of International Drug Discovery Science and Technology-2018
Scientific Program
 
BIT's 16th Annual Congress of International Drug Discovery Science and Technology-2018
Theme: Rethinking the Next Big Things in Pharma Innovations
Time: August 16-19, 2018 
Place: Boston Marriott Cambridge, USA
 
Scientific Program
Stream 1 Stream 2 Stream 3 Stream 4 Stream 5

 

Opening Ceremony and Plenary Forum

Day 1: Morning, Thursday, August 16, 2018

Place: Salon III, 2nd Floor
09:20-11:30

Moderator:  Dr. Qun (Max) Dang, Vice President & Global Head of BD and External Innovation, PR&D, Qilu Pharmaceutical, China
Time FaceOn Speeches and Speakers
09:20-09:25 Moderator's Introduction
09:25-09:50 Title: Iconoclast Therapeutics: Breaking All the Rules of Engagement

Dr. Gregory L. Verdine, Founder, CEO & Erving Professor, FogPharma and LifeMine Therapeutics; Harvard University and Harvard Medical School, USA

09:50-10:15

Title: Optimization of a Novel EphA2-antibody Directed Nanotherapeutic for the Treatment of Solid Tumors

Dr. Daryl C. Drummond, Senior Vice President and Head of Research, Merrimack Pharmaceuticals, USA

10:15-10:40 Title: Remote Patient Monitoring in Clinical Trials: Ready or Not, Here It Comes
Dr. Kenneth G. Faulkner, Corporate Vice President, Patient Technology Solutions, PAREXEL, USA
10:40-11:05

Title: External Collaboration - A Must-have for Future Pharma Innovations

Dr. Qun (Max) Dang, Vice President & Global Head of BD and External Innovation, PR&D, Qilu Pharmaceutical, China
11:05-11:30

Title: Building a Brighter/Better Future for Drug Discovery

Dr. Tom Mander, Chief Operating Officer, Domainex Ltd., UK
12:00-13:00 Lunch

 

© 2003-2018 All rights reserved by BIT Congress Inc.
Contact Us: Tel: 0086-411-84799609, Fax: 0086-411-84796897